Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

RedHill Biopharma RDHL Positive Phase III with BEKINDA for gastroenteritis

$
0
0
Edison Investment Research Pharmaceutical & healthcare RedHill Biopharma RedHill BioPharma delivered a flurry of news recently including a major R&D milestone when a Phase III trial with BEKINDA 24mg showed that the drug was beneficial to gastro...

Viewing all articles
Browse latest Browse all 2985

Trending Articles